Leukopenia as a Possible Biomarker for Overall Survival in Glioblastoma Patients Treated with Temozolomide

被引：0
|
作者：
Ho, Ka-wai G. [1 ]
Wong, Eric T. [1 ]
Uhlmann, Erik J. [1 ]
机构：
[1] Harvard Med Sch, Beth Israel Deaconess Med Ctr, Neurol, Boston, MA USA
来源：
NEUROLOGY | 2018年 / 90卷
关键词：
D O I：
暂无
中图分类号：
R74 [神经病学与精神病学];
学科分类号：
摘要：
P6.167
引用
收藏
页数：2
相关论文
共 50 条
  • [41] MYOINOSITOL AS A PREDICTIVE BASELINE BIOMARKER FOR OVERALL SURVIVAL OF PATIENTS WITH RECURRENT GLIOBLASTOMA TREATED WITH BEVACIZUMAB: A 1H-MAGNETIC RESONANCE SPECTROSCOPY STUDY.
    Steidl, E.
    Pilatus, U.
    Steinbach, J. P.
    Zanella, F.
    Ronellenfitsch, M. W.
    Hattingen, E.
    Baehr, O.
    NEURO-ONCOLOGY, 2016, 18 : 28 - 28
  • [42] Absolute lymphocyte count as a prognostic biomarker for overall survival in patients with advanced melanoma treated with ipilimumab
    Postow, Michael A.
    Chasalow, Scott D.
    Kuk, Deborah
    Panageas, Katherine S.
    Cheng, Michael L.
    Yuan, Jianda
    Wolchok, Jedd D.
    MELANOMA RESEARCH, 2020, 30 (01) : 71 - 75
  • [43] SURVIVAL GAIN AND IMMUNE RESPONSE IN GLIOBLASTOMA PATIENTS TREATED WITH DENDRITIC CELL IMMUNOTHERAPY BEFORE AND DURING ADJUVANT TEMOZOLOMIDE
    Pellegatta, S.
    Eoli, M.
    Anghileri, E.
    Frigerio, S.
    Cuccarini, V.
    Antozzi, C.
    Pollo, B.
    Pessina, S.
    Bruzzone, M.
    Finocchiaro, G.
    NEURO-ONCOLOGY, 2016, 18 : 6 - 6
  • [44] Influence of incidental radiation dose in the subventricular zone on survival in patients with glioblastoma multiforme treated with surgery, radiotherapy, and temozolomide
    P. Foro Arnalot
    O. Pera
    N. Rodriguez
    X. Sanz
    A. Reig
    I. Membrive
    A. Ortiz
    R. Granados
    M. Algara
    Clinical and Translational Oncology, 2017, 19 : 1225 - 1231
  • [45] Mgmt expression correlates with response rate and survival in patients with inoperable glioblastoma (GBM) treated with neoadjuvant temozolomide (TMZ)
    Barrie, M.
    Eudes, N.
    Boucard, C.
    Metellus, P.
    Fuentes, S.
    Honoré, S.
    Dufour, H.
    Figarella-Branger, D.
    Chinot, O.
    NEURO-ONCOLOGY, 2006, 8 (04) : 352 - 352
  • [46] ABCB1 single-nucleotide variants and survival in patients with glioblastoma treated with radiotherapy concomitant with temozolomide
    Annika Malmström
    Malgorzata Łysiak
    Lisa Åkesson
    Ingrid Jakobsen
    Munila Mudaisi
    Peter Milos
    Martin Hallbeck
    Victoria Fomichov
    Helle Broholm
    Kirsten Grunnet
    Hans Skovgaard Poulsen
    Charlotte Bratthäll
    Michael Strandeus
    Angeliki Papagiannopoulou
    Marie Stenmark-Askmalm
    Henrik Green
    Peter Söderkvist
    The Pharmacogenomics Journal, 2020, 20 : 213 - 219
  • [47] ABCB1 single-nucleotide variants and survival in patients with glioblastoma treated with radiotherapy concomitant with temozolomide
    Malmstrom, Annika
    Lysiak, Malgorzata
    akesson, Lisa
    Jakobsen, Ingrid
    Mudaisi, Munila
    Milos, Peter
    Hallbeck, Martin
    Fomichov, Victoria
    Broholm, Helle
    Grunnet, Kirsten
    Poulsen, Hans Skovgaard
    Bratthall, Charlotte
    Strandeus, Michael
    Papagiannopoulou, Angeliki
    Stenmark-Askmalm, Marie
    Green, Henrik
    Soderkvist, Peter
    PHARMACOGENOMICS JOURNAL, 2020, 20 (02): : 213 - 219
  • [48] Current survival statistics for patients with newly diagnosed glioblastoma treated with radiation and temozolomide on research studies in the United States
    Grossman, S. A.
    Ye, X.
    Piantadosi, S.
    Desideri, S.
    Nabors, L. B.
    Rosenfeld, M.
    Fisher, J.
    JOURNAL OF CLINICAL ONCOLOGY, 2009, 27 (15)
  • [49] MGMT expression correlates with response rate and survival in patients with inoperable glioblastoma (GBM) treated with neoadjuvant temozolomide (TMZ).
    Barrie, M.
    Eudes, N.
    Metellus, P.
    Fuentes, S.
    Honore, S.
    Boucard, C.
    Dufour, H.
    Figarella-Branger, D.
    Chinot, O.
    JOURNAL OF CLINICAL ONCOLOGY, 2006, 24 (18) : 76S - 76S
  • [50] Modeling long-term survival outcomes in glioblastoma patients treated with TTFields plus temozolomide and temolozomide monotherapy
    Guzauskas, Greg
    Wang, Bruce
    Salzberg, Marc
    CANCER RESEARCH, 2017, 77
12345